Cinnamomum cassia Presl: A Review of Its Traditional Uses, Phytochemistry, Pharmacology and Toxicology

被引:137
作者
Zhang, Chunling [1 ]
Fan, Linhong [1 ]
Fan, Shunming [1 ]
Wang, Jiaqi [1 ]
Luo, Ting [1 ]
Tang, Yu [1 ]
Chen, Zhimin [1 ]
Yu, Lingying [1 ]
机构
[1] Chengdu Univ Tradit Chinese Med, Sch Pharm, Chengdu 611137, Sichuan, Peoples R China
来源
MOLECULES | 2019年 / 24卷 / 19期
关键词
Cinnamomum cassia Presl; traditional uses; phytochemistry; pharmacology; toxicology; SQUAMOUS-CELL CARCINOMA; ESSENTIAL OIL; IN-VITRO; INHIBITORY-ACTIVITY; MESENCHYMAL TRANSITION; ANTIBACTERIAL ACTIVITY; EXTRACT; BARKS; CINNAMALDEHYDE; RECEPTOR;
D O I
10.3390/molecules24193473
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cinnamomum cassia Presl is a tropical aromatic evergreen tree of the Lauraceae family, commonly used in traditional Chinese medicine. It is also a traditional spice, widely used around the world. This paper summarizes the achievements of modern research on C. cassia, including the traditional uses, phytochemistry, pharmacology and toxicology. In addition, this review also discusses some significant issues and the potential direction of future C. cassia research. More than 160 chemicals have been separated and identified from C. cassia. The main constituents of C. cassia are terpenoids, phenylpropanoids, glycosides, etc. Modern studies have confirmed that C. cassia has a wide range of pharmacological effects, including antitumour, anti-inflammatory and analgesic, anti-diabetic and anti-obesity, antibacterial and antiviral, cardiovascular protective, cytoprotective, neuroprotective, immunoregulatory effects, anti-tyrosinase activity and other effects. However, the modern studies of C. cassia are still not complete and more in-depth investigations need to be conducted in alimentotherapy, health product, toxicity and side effects, and more bioactive components and potential pharmacological effects need to be explored in the future.
引用
收藏
页数:31
相关论文
共 114 条
  • [1] Cinnamomum cassia exhibits antileishmanial activity against Leishmania donovani infection in vitro and in vivo
    Afrin, Farhat
    Chouhan, Garima
    Islamuddin, Mohammad
    Want, Muzamil Y.
    Ozbak, Hani A.
    Hemeg, Hassan A.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2019, 13 (05):
  • [2] [Anonymous], 2018, SHANGHAI J TRADIT CH
  • [3] Prevention of oxaliplatin-induced peripheral neuropathy by a polyamine-reduced diet-NEUROXAPOL: protocol of a prospective, randomised, controlled, single-blind and monocentric trial
    Balayssac, David
    Ferrier, Jeremy
    Pereira, Bruno
    Gillet, Brigitte
    Petorin, Caroline
    Vein, Julie
    Libert, Frederic
    Eschalier, Alain
    Pezet, Denis
    [J]. BMJ OPEN, 2015, 5 (04):
  • [4] Phytochemicals of Cinnamomi Cortex: Cinnamic Acid, but not Cinnamaldehyde, Attenuates Oxaliplatin-Induced Cold and Mechanical Hypersensitivity in Rats
    Chae, Hyeon Kyeong
    Kim, Woojin
    Kim, Sun Kwang
    [J]. NUTRIENTS, 2019, 11 (02):
  • [5] Chemical composition and tyrosinase inhibitory activity of Cinnamomum cassia essential oil
    Chang, Chen-Tien
    Chang, Wen-Lun
    Hsu, Jaw-Cherng
    Shih, Ying
    Chou, Su-Tze
    [J]. BOTANICAL STUDIES, 2013, 54
  • [6] Cinnamomum cassia essential oil and its major constituent cinnamaldehyde induced cell cycle arrest and apoptosis in human oral squamous cell carcinoma HSC-3 cells
    Chang, Wen-Lun
    Cheng, Fu-Chou
    Wang, Shu-Ping
    Chou, Su-Tze
    Shih, Ying
    [J]. ENVIRONMENTAL TOXICOLOGY, 2017, 32 (02) : 456 - 468
  • [7] Visceral leishmaniasis: What are the needs for diagnosis, treatment and control?
    Chappuis, Francois
    Sundar, Shyam
    Hailu, Asrat
    Ghalib, Hashim
    Rijal, Suman
    Peeling, Rosanna W.
    Alvar, Jorge
    Boelaert, Marleen
    [J]. NATURE REVIEWS MICROBIOLOGY, 2007, 5 (11) : 873 - 882
  • [8] Differentiating parts of Cinnamomum cassia using LC-qTOF-MS in conjunction with principal component analysis
    Chen, Pei-Yi
    Yu, Jhe-Wei
    Lu, Fen-Ling
    Lin, Mei-Chih
    Cheng, Hwei-Fang
    [J]. BIOMEDICAL CHROMATOGRAPHY, 2016, 30 (09) : 1449 - 1457
  • [9] Chinese Pharmacopoeia Commission, 2015, PHARM PEOPL REP CHIN, P767
  • [10] Chinese Pharmacopoeia Commission, 2015, PHARM PEOPL REP CH 1, P795